Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02754219
What this trial is testing

Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction

Who this might be right for
Liver Dysfunction
Dong-A ST Co., Ltd. 24
Post-approval studies (Phase 4)Study completedNCT01467401
What this trial is testing

Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 292
Large-scale testing (Phase 3)Study completedNCT03259789
What this trial is testing

Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Who this might be right for
Type2 Diabetes Mellitus
Theracos 351
Early research (Phase 1)Ended earlyNCT00637338
What this trial is testing

Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 42
Large-scale testing (Phase 3)Study completedNCT02906917
What this trial is testing

A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 532
Not applicableStudy completedNCT03332927
What this trial is testing

Effect of Egg Consumption on Cardiometabolic Health in Prediabetic Subjects.

Who this might be right for
PreDiabetes
Midwest Center for Metabolic and Cardiovascular Research 39
Early research (Phase 1)Study completedNCT02211261
What this trial is testing

Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 84
Testing effectiveness (Phase 2)Study completedNCT01804842
What this trial is testing

Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM

Who this might be right for
Type 2 Diabetes Mellitus
Elcelyx Therapeutics, Inc. 26
Testing effectiveness (Phase 2)Study completedNCT03645421
What this trial is testing

Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 61
Early research (Phase 1)Study completedNCT01128985
What this trial is testing

A Pharmacokinetic and Pharmacodynamic Study to Determine Blood Levels of JNJ-28431754 (Canagliflozin) in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 39
Testing effectiveness (Phase 2)Study completedNCT01498185
What this trial is testing

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
AstraZeneca 171
Not applicableStudy completedNCT04763525
What this trial is testing

Efficacy of Pythagorean Self-Awareness for Aging Biomarkers Improvement, in T2D Patients and Healthy Individuals.

Who this might be right for
Type 2 Diabetes MellitusTelomere Shortening
National and Kapodistrian University of Athens 48
Testing effectiveness (Phase 2)Study completedNCT00856908
What this trial is testing

Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes

Who this might be right for
Type II Diabetes
AstraZeneca 20
Large-scale testing (Phase 3)Study completedNCT00918138
What this trial is testing

Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg

Who this might be right for
Type 2 Diabetes
AstraZeneca 219
Testing effectiveness (Phase 2)Study completedNCT00961662
What this trial is testing

A Clinical Study to Evaluate the Effect of Naturlose (Tagatose)

Who this might be right for
Type 2 Diabetes
Robert Lodder 161
Not applicableStudy completedNCT02105103
What this trial is testing

European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.

Who this might be right for
Type 2 Diabetes, Type 1 Diabetes
Hoffmann-La Roche 80
Large-scale testing (Phase 3)Study completedNCT00290927
What this trial is testing

Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 390
Early research (Phase 1)Study completedNCT06086912
What this trial is testing

A Clinical Study to Compare the Bioavailability of HR17031 in Healthy Subjects at Different Sites

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 24
Post-approval studies (Phase 4)Study completedNCT00654745
What this trial is testing

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

Who this might be right for
Type 2 DiabetesHypertension
Daiichi Sankyo 207
Large-scale testing (Phase 3)Study completedNCT00225277
What this trial is testing

Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 547
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation